Orphenadrine Citrate
NDC 0591-3222, Orphenadrine Citrate, injection, from Actavis Pharma, Inc..
- Product NDC
- 0591-3222
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA084779
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0591-3222 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ORPHENADRINE CITRATE30 mg/mL
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0591-3222-47 | 00591322247 | 10 AMPULE in 1 CARTON (0591-3222-47) / 2 mL in 1 AMPULE (0591-3222-02) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/aec8ad3a-f717-4e74-b7b9-19debdaad79a
Use it
Look up 0591-3222 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0591-3222 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0591-3222. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.